Skip to main content

Advertisement

Table 1 General characteristics of the study population

From: Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP

Characteristic Men (n = 373) Women (n = 499) p*
Age (years) 49 (38; 60) 49 (40; 59) 0.94
Smoking (%)    < 0.01
 Never smoker 32.7 49.7  
 Former smoker 44.8 28.5  
 Current smoker 25.5 21.8  
Physically active (%) 74.3 73.7 0.93
Waist circumference (cm) 93 (85; 101) 80 (73; 89) < 0.01
NT-probnp (ng/L) 32 (19; 55) 68 (41; 124) < 0.01
Triglycerides (mmol/L) 1.27 (0.92; 1.88) 1.13 (0.81; 1.60) < 0.01
HDL-cholesterol (mmol/L) 1.29 (1.11; 1.49) 1.58 (1.35; 1.83) < 0.01
LDL-cholesterol (mmol/L) 3.35 (2.73; 3.96) 3.31 (2.72; 3.95) 0.55
Total cholesterol (mmol/L) 5.3 (4.5; 6.0) 5.5 (4.9; 6.2) < 0.01
Egfr (mL/min/1.73 m2) 98 (89; 108) 98 (86; 107) 0.28
ALT (µkatal/L) 0.46 (0.35; 0.64) 0.30 (0.24; 0.41) < 0.01
Ejection fraction (%) 72 (65; 77) 73 (68; 79) < 0.01
Self-reported HF (%) 1.9% 2% 1.00
Adiponectin (ng/mL) 5644 (3814; 7782) 8851 (6333; 12,102) < 0.01
  1. Continuous data are expressed as median (25th percentile; 75th percentile); nominal data are given as percentages. * χ2-test (nominal data) or Mann–Whitney-U test (interval data) were performed to compare men and women
  2. HDL high density lipoprotein, LDL low-density lipoprotein, NT-proBNP N-terminal prohormone of brain natriuretic peptide, eGFR estimated glomerular filtration rate, ALT alanine aminotransferase, HF heart failure